Ichimura Hirona, Ichikawa Satoshi, Ono Koya, Inokura Kyoko, Hoshi Yosuke, Shirai Tsuyoshi, Fukuhara Noriko, Yokoyama Hisayuki, Fujii Hiroshi, Harigae Hideo
Department of Hematology, Tohoku University Hospital.
Department of Rheumatology, Tohoku University Hospital.
Tohoku J Exp Med. 2023 Aug 11;260(4):301-304. doi: 10.1620/tjem.2023.J037. Epub 2023 May 11.
Macrophage activation syndrome (MAS) is a potentially fatal complication of rheumatic diseases, characterized by activated macrophages with hemophagocytosis and multiple organ damage. We report a case of MAS associated with systemic lupus erythematosus that initially presented with severe liver dysfunction. Although it was improved with steroids and plasmapheresis, severe pancytopenia was subsequently experienced, and the bone marrow showed severe aplasia similar to aplastic anemia. Nevertheless, the administration of immunosuppressants resulted in the recovery of blood counts within two weeks. When severe MAS results in cytokine overproduction, bone marrow aplasia may occur, for which immunosuppressive therapy may be highly effective.
巨噬细胞活化综合征(MAS)是风湿性疾病的一种潜在致命并发症,其特征为活化的巨噬细胞伴噬血细胞现象和多器官损害。我们报告一例与系统性红斑狼疮相关的MAS病例,该病例最初表现为严重肝功能障碍。尽管使用类固醇和血浆置换后病情有所改善,但随后出现了严重全血细胞减少,骨髓显示出与再生障碍性贫血相似的严重发育不全。然而,给予免疫抑制剂后,血细胞计数在两周内恢复。当严重的MAS导致细胞因子过度产生时,可能会发生骨髓发育不全,对此免疫抑制治疗可能非常有效。